Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Treatment of COVID-19 Infection by UDCA in Patients With Autoimmune Liver Disease and Its Clinical Prognosis

NCT05812612 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT05812612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05812612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Treatment of COVID-19 Infection by UDCA in Patients With Autoimmune Liver Disease and Its Clinical Prognosis
Lead sponsor
Beijing Ditan Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 30, 2023
Completion date
December 30, 2023
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection